Vivekanand Jha's Publications

About Vivekanand Jha's Publications

Executive Director, The George Institute for Global Health, India
  • PHD

  • Cholecalciferol supplementation and angiogenic markers in chronic kidney disease

    PLOS ONE Date published:

  • Hydroxychloroquine plus personal protective equipment versus personal protective equipment alone for the prevention of laboratory-confirmed COVID-19 infections among healthcare workers: a multicentre, parallel-group randomised controlled trial from India

    BMJ Open Date published:

  • Effect of Oral Methylprednisolone on Decline in Kidney Function or Kidney Failure in Patients With IgA Nephropathy

    JAMA Date published:

  • Peritoneal catheter insertion: combating barriers through policy change

    Clinical Kidney Journal Date published:

  • Mesenchymal Stem/Stromal Cells: IMMUNE CELL INTERPLAY IN RENAL TRANSPLANT PATIENTS POST MESENCHYMAL STROMAL CELL INFUSION

    Cytotherapy Date published:

  • Global multi-stakeholder endorsement of the MAFLD definition

    The Lancet Gastroenterology & Hepatology Date published:

  • MO534: Associations of Haemoglobin Values and Rate of Changes With Mace in the ASCEND-D Randomised Clinical Trial

    Nephrology Dialysis Transplantation Date published:

  • MO535: Associations of Haemoglobin Values and Rate of Changes With MACE in the ASCEND-ND Randomised Clinical Trial

    Nephrology Dialysis Transplantation Date published:

  • Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY disease (CLARITY): statistical analysis plan for a randomised controlled Bayesian adaptive sample size trial

    Trials Date published:

  • World wellbeing watch

    BMJ Date published:

  • Efficacy and Safety of Daprodustat for Treatment of Anemia of Chronic Kidney Disease in Incident Dialysis Patients

    JAMA Internal Medicine Date published:

  • Early Identification of CKD-A Scoping Review of the Global Populations

    Kidney International Reports Date published:

  • Long-term outcomes of dexamethasone 12 mg versus 6 mg in patients with COVID-19 and severe hypoxaemia

    Intensive Care Medicine Date published:

  • Kidney complications of parasitic diseases

    Nature Reviews Nephrology Date published:

  • Premature Death in Kidney Transplant Recipients: The Time for Trials is Now

    Journal of the American Society of Nephrology Date published:

  • ASCOT ADAPT study of COVID-19 therapeutics in hospitalised patients: an international multicentre adaptive platform trial

    Unknown Date published: